← All instruments/Stock/LLY
中EN
LLY logo

LLY

Stock

Eli Lilly and Co

LLY-USDT-SWAP
$1,063.52−$18.68-1.73%today
Close · 58 min ago

Eli Lilly and Company is a global pharma giant developing diabetes, weight-loss, and oncology drugs.

Prev close ▴$1,082.20
High$1,078.22
Open$1,070.78
Low$1,052.15
today
HQ
US
Sector
Pharmaceuticals
Issued
1985-01-13
Shares out.
942M

Performance

57 min ago
52-week range84% of range
$623.782025-08-08
$1,149.102026-05-28
5D+1.64%
MTD-2.06%
13W+2.87%
26W+2.12%
YTD+0.70%
52W+46.71%
Avg volume (10D)3.3M
Avg volume (3M)3.2M

Key statistics

57 min ago
Valuation
Market cap
$1.01T
Enterprise value
$1.04T
P/E (TTM)
39.81
Forward P/E
27.51
P/E (annual)
48.75
PEG
1.37
P/B
38.29
P/S (TTM)
13.93
P/S (annual)
15.44
EV / EBITDA
31.11×
EV / Revenue
14.45×
EPS (TTM)
$28.15
EPS (annual)
$22.95
Basic EPS (TTM)
$28.15
Book value / share
$28.09
Profitability
Gross margin
82.83%
Operating margin
43.63%
Net margin
34.99%
Return on equity (ROE)
101.31%
Return on assets (ROA)
22.73%
Return on investment (ROI)
37.71%
EBITDA / share
$37.37
Revenue / share (TTM)
$80.64
Growth
Revenue growth (TTM YoY)
+47.44%
Revenue growth (Q YoY)
+55.55%
EPS growth (TTM YoY)
+128.83%
Dividend
Dividend yield (indicated)
0.64%
Dividend yield (TTM)
0.56%
Dividend / share (TTM)
$5.91
Payout ratio
22.10%
Financial health
Current ratio
1.58
Quick ratio
0.78
Debt / equity
1.60
LT debt / equity
1.54
Risk
Beta
0.52
Volatility (3M)
37.57%

Analyst ratings

57 min ago
Buy39 analysts
As of 2026-06-01
Strong Buy11
Buy20
Hold7
Sell1
Strong Sell0

Earnings

57 min ago
Last quarterBeat +27.04%
FY2026 Q1 · 2026-03-31
Actual EPS$8.55
Est. EPS$6.73
Surprise$1.82
Next report
2026-08-05
FY2026 Q2
Est. EPS$8.90
Est. revenue$20.53B

Related news

57 min ago
Trade on TelegramTrade on OKX